Company profile: Meds
1.1 - Company Overview
Company description
- Provider of online pharmacy services selling prescription and non-prescription drugs with permission from the Medical Products Agency, plus health and wellness products, beauty and personal care items, and pet medications. Offers delivery to your door or a local pickup point and licensed pharmacists for advice; operates without physical stores and focuses on fast delivery.
Products and services
- Non-Prescription Medication: Supplies OTC-classified drugs for colds, headaches, and allergies, with rapid home or pickup delivery from an online-only pharmacy operating without a physical store
- Pharmaceutical Advice: Licensed-pharmacist-led guidance service offering personalized medication and health advice, clarifying use and selection during online ordering, enhancing safety and understanding for remote customers
- Prescription Medication: MPA-authorized online ordering system for prescription drugs, delivering to your door or local pickup point with accelerated dispatch, operating without a physical store
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Meds
Medlanes
HQ: Germany
Website
- Description: Provider of an online healthcare platform that lets users connect with doctors from anywhere at any time via a mobile app to request medical advice, serving as a first contact point to healthcare on the internet.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medlanes company profile →
Antidote Health
HQ: United States
Website
- Description: Provider of an AI-based health platform offering 24/7 virtual doctor visits; healthcare plans covering medical, behavioral health, telehealth, dental, pediatric care, and vision; low- to no-cost prescription medications; mental health care with assessments and regular copay-free visits; virtual pediatric care without copay; and chronic condition management with potential $0 copay.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Antidote Health company profile →
Felix
HQ: Canada
Website
- Description: Provider of digital healthcare services offering online health assessments evaluated by licensed healthcare practitioners, consultations and treatment plans, home delivery of prescription medications, and direct insurance billing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Felix company profile →
TreatMD
HQ: United States
Website
- Description: Provider of an international, on-demand healthcare platform that extends beyond traditional telehealth/telemedicine, with telehealth as just one component.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TreatMD company profile →
Home Access Health
HQ: United States
Website
- Description: Provider of laboratory testing services delivering health information through simple, self-collected lab tests. Founded in 1996 and based in Hoffman Estates, Illinois; now a subsidiary of Everly Health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Home Access Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Meds
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Meds
2.2 - Growth funds investing in similar companies to Meds
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Meds
4.2 - Public trading comparable groups for Meds
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →